HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 97/4/1291    most recent 00366.2004v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (17) Citing Articles via Google Scholar Google Scholar Articles by Wilkins, B. W. Articles by Minson, C. T. Search for Related Content PubMed PubMed Citation Articles by Wilkins, B. W. Articles by Minson, C. T.

Mechanisms of vasoactive intestinal peptide-mediated vasodilation in human skin

¹Department of Human Physiology and ²Institute of Neuroscience, University of Oregon, Eugene, Oregon 97403

Submitted 6 April 2004 ; accepted in final form 19 May 2004

Vasoactive intestinal peptide (VIP) is known to induce histamine release in human skin and to include a nitric oxide (NO)-dependent dilation in several other vascular beds. However, the relative contribution of histamine and NO to VIP-mediated vasodilation in human skin is unknown. Forty-three subjects volunteered to participate in two studies designed to examine the mechanism of VIP-mediated vasodilation in human skin. Study 1 examined the contribution of NO in the skin blood flow response to eight doses of VIP ranging from 25 to 800 pmol. In addition, study 1 examined a specific role for NO in VIP-mediated dilation. Study 2 examined the relative contribution of NO and histamine to VIP-mediated dilation via H₁ and H₂ histamine receptors. Infusions were administered to skin sites via intradermal microdialysis. Red blood cell flux was measured by using laser-Doppler flowmetry (LDF), and cutaneous vascular conductance (CVC; LDF/mean arterial pressure) was calculated and normalized to maximal vasodilation. VIP-mediated vasodilation includes a NO-dependent component at doses above 100 pmol, where NO synthase inhibition significantly attenuates CVC (P < 0.05). Inhibition of H₁ receptors attenuates the rise in CVC to exogenous VIP (P < 0.05); however, combined H₁-receptor inhibition and NO synthase inhibition further reduced VIP-mediated vasodilation compared with either H₁ inhibition or NO synthase inhibition alone (P < 0.05). In contrast to H₁-receptor inhibition, H₂-receptor inhibition did not affect vasodilation to exogenous VIP. Thus, in human skin, VIP-mediated vasodilation includes a NO-dependent component that could not be explained by H₁- and H₂-receptor activation.

cutaneous circulation; nitric oxide; neuropeptides; histamine receptors

This article has been cited by other articles:

				G. J. Hodges, C. Chiu, W. A. Kosiba, K. Zhao, and J. M. Johnson The effect of microdialysis needle trauma on cutaneous vascular responses in humans J Appl Physiol, April 1, 2009; 106(4): 1112 - 1118. [Abstract] [Full Text] [PDF]

				D. L. Kellogg Jr., G. J. Hodges, C. R. Orozco, T. M. Phillips, J. L. Zhao, and J. M. Johnson Cholinergic mechanisms of cutaneous active vasodilation during heat stress in cystic fibrosis J Appl Physiol, September 1, 2007; 103(3): 963 - 968. [Abstract] [Full Text] [PDF]

				B. W. Wilkins, E. A. Martin, S. K. Roberts, and M. J. Joyner Preserved reflex cutaneous vasodilation in cystic fibrosis does not include an enhanced nitric oxide-dependent mechanism J Appl Physiol, June 1, 2007; 102(6): 2301 - 2306. [Abstract] [Full Text] [PDF]

				B. J. Wong and C. T. Minson Neurokinin-1 receptor desensitization attenuates cutaneous active vasodilatation in humans J. Physiol., December 15, 2006; 577(3): 1043 - 1051. [Abstract] [Full Text] [PDF]

				L. A. Holowatz, C. S. Thompson, and W. L. Kenney Acute ascorbate supplementation alone or combined with arginase inhibition augments reflex cutaneous vasodilation in aged human skin Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2965 - H2970. [Abstract] [Full Text] [PDF]

				G. R. McCord, J.-L. Cracowski, and C. T. Minson Prostanoids contribute to cutaneous active vasodilation in humans Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R596 - R602. [Abstract] [Full Text] [PDF]

				L. A. Holowatz, C. S. Thompson, and W. L. Kenney L-Arginine supplementation or arginase inhibition augments reflex cutaneous vasodilatation in aged human skin J. Physiol., July 15, 2006; 574(2): 573 - 581. [Abstract] [Full Text] [PDF]

				D. L. Kellogg Jr In vivo mechanisms of cutaneous vasodilation and vasoconstriction in humans during thermoregulatory challenges J Appl Physiol, May 1, 2006; 100(5): 1709 - 1718. [Abstract] [Full Text] [PDF]

				B. J. Wong, S. J. Williams, and C. T. Minson Minimal role for H1 and H2 histamine receptors in cutaneous thermal hyperemia to local heating in humans J Appl Physiol, February 1, 2006; 100(2): 535 - 540. [Abstract] [Full Text] [PDF]

				B. W. Wilkins, B. J. Wong, N. J. Tublitz, G. R. McCord, and C. T. Minson Vasoactive intestinal peptide fragment VIP10-28 and active vasodilation in human skin J Appl Physiol, December 1, 2005; 99(6): 2294 - 2301. [Abstract] [Full Text] [PDF]

				B. J Wong, N. J Tublitz, and C. T Minson Neurokinin-1 receptor desensitization to consecutive microdialysis infusions of substance P in human skin J. Physiol., November 1, 2005; 568(3): 1047 - 1056. [Abstract] [Full Text] [PDF]

				L. A Holowatz, C. S Thompson, C. T Minson, and W. L. Kenney Mechanisms of acetylcholine-mediated vasodilatation in young and aged human skin J. Physiol., March 15, 2005; 563(3): 965 - 973. [Abstract] [Full Text] [PDF]

				B. J Wong, B. W Wilkins, and C. T Minson H1 but not H2 histamine receptor activation contributes to the rise in skin blood flow during whole body heating in humans J. Physiol., November 1, 2004; 560(3): 941 - 948. [Abstract] [Full Text] [PDF]